Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Protective Effects against Brucella abortus 544 Infection in a Murine Macrophage Cell Line and in a Mouse Model via Treatment with Sirtuin 1 Activators Resveratrol, Piceatannol and Ginsenoside Rg3

  • Alisha Wehdnesday Bernardo Reyes (Department of Veterinary Paraclinical Sciences, College of Veterinary Medicine, University of the Philippines Los Banos) ;
  • Heejin Kim (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Tran Xuan Ngoc Huy (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Trang Thi Nguyen (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Wongi Min (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Hu Jang Lee (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Jin Hur (College of Veterinary Medicine, Jeonbuk National University) ;
  • John Hwa Lee (College of Veterinary Medicine, Jeonbuk National University) ;
  • Suk Kim (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
  • Received : 2022.09.19
  • Accepted : 2023.01.09
  • Published : 2023.04.28
Download PDF
⟨ Previous Next ⟩

Abstract

Brucellosis is a contagious zoonotic disease that infects millions of people annually with hundreds of millions more being exposed. It is caused by Brucella, a highly infectious bacterial species capable of infecting humans with an estimated dose of 10-100 organisms. Sirtuin 1 (SIRT1) has been reported to contribute to prevention of viral diseases as well as a chronic infection caused by Mycobacterium bovis. Here, we investigated the role of SIRT1 in the establishment of Brucella abortus infection in both in vitro and in vivo systems using the reported SIRT1 activators resveratrol (RES), piceatannol (PIC), and ginsenoside Rg3 (Rg3). In RAW264.7 cells, SIRT1 activators did not alter the adherence of Brucella or Salmonella Typhimurium. However, reduced uptake of Brucella was observed in cells treated with PIC and Rg3, and survival of Brucella within the cells was only observed to decrease in cells that were treated with Rg3, while PIC treatment reduced the intracellular survival of Salmonella. SIRT1 treatment in mice via oral route resulted in augmented Brucella resistance for PIC and Rg3, but not RES. PIC treatment favors Th2 immune response despite reduced serum pro-inflammatory cytokine production, while Rg3-treated mice displayed high IL-12 and IFN-γ serum production. Overall, our findings encourage further investigation into the complete mechanisms of action of the different SIRT1 activators used as well as their potential benefit as an effective alternative approach against intracellular and extracellular pathogens.

Keywords

Acknowledgement

This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the Animal Disease Management Technology Development Program, funded by the Ministry of Agriculture, Food and Rural Affairs (122001021SB01061382116530000).

References

  1. Dadar M, Tiwari R, Sharun K, Dhama K. 2021. Importance of brucellosis control programs of livestock on the improvement of one health. Vet. Q 41: 137-151. https://doi.org/10.1080/01652176.2021.1894501
  2. Oliveira SC. 2021. Host immune responses and pathogenesis to Brucella spp. infection. Pathogens 10: 288.
  3. Jamil T, Melzer F, Njeru J, El-Adawy H, Neubauer H, Wareth G. 2017. Brucella abortus: current research and future trends. Curr. Clin. Microbiol. Rep. 4: 1-10. https://doi.org/10.1007/s40588-017-0052-z
  4. Laine CG, Scott HM, Arenas-Gamboa AM. 2022. Human brucellosis: widespread information deficiency hinders an understanding of global disease frequency. PLoS Negl. Trop. Dis. 16: e0010404.
  5. Christopher S, Umapathy BL, Ravikumar KL. 2010. Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis. J. Lab. Physicians 2: 55-60. https://doi.org/10.4103/0974-2727.72149
  6. von Bargen K, Gorvel JP, Salcedo SP. 2012. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol. Rev. 36: 533-562. https://doi.org/10.1111/j.1574-6976.2012.00334.x
  7. Karponi G, Kritas SK, Papadopoulou G, Akrioti EK, Papanikolaou E, Petridou E. 2019. Development of a CRISPR/Cas9 system against ruminant animal brucellosis. BMC Vet. Res. 15: 422.
  8. Ryu S, Soares Magalhaes RJ, Chun BC. 2019. The impact of expanded brucellosis surveillance in beef cattle on human brucellosis in Korea: an interrupted time-series analysis. BMC Infect. Dis. 19: 201.
  9. Yoon H, Moon OK, Lee SH, Lee WC, Her M, Jeong W, et al. 2014. Epidemiology of brucellosis among cattle in Korea from 2001 to 2011. J. Vet. Sci. 15: 537-543. https://doi.org/10.4142/jvs.2014.15.4.537
  10. Solis Garcia del Pozo J, Solera J. 2012. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One 7: e32090.
  11. Lalsiamthara J, Lee JH. 2017. Development and trial of vaccines against Brucella. J. Vet. Sci. 18: 281-290. https://doi.org/10.4142/jvs.2017.18.S1.281
  12. Opal SM, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, et al. 2016. Pharmacological SIRT1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis. Shock 15: 411-418. https://doi.org/10.1097/SHK.0000000000000528
  13. Crotty Alexander LE, Marsh BJ, Timmer AM, Lin AE, Zainabadi K, Czopik A, et al. 2013. Myeloid cell sirtuin-1 expression does not alter host immune responses to Gram-negative endotoxemia or Gram-positive bacterial infection. PLoS One 8: e84481.
  14. Radkar V, Hardej D, Lau-Cam C, Billack B. 2007. Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells. Arh. Hig. Rada Toksikol. 58: 293-304. https://doi.org/10.2478/v10004-007-0020-8
  15. Zykova TA, Zhu F, Zhai X, Ma WY, Ermakova SP, Lee KW, et al. 2008. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinog. 47: 797-805. https://doi.org/10.1002/mc.20437
  16. Gagnaire A, Gorvel L, Papadopoulos A, Von Bargen K, Mege JL, Gorvel JP. 2016. COX-2 Inhibition reduces Brucella bacterial burden in draining lymph nodes. Front. Microbiol. 7: 1987.
  17. Lee HJ, Kang MG, Cha HY, Kim YM, Lim Y, Yang SJ. 2019. Effects of piceatannol and resveratrol on sirtuins and hepatic inflammation in high-fat diet-fed mice. J. Med. Food 22: 833-840. https://doi.org/10.1089/jmf.2018.4261
  18. Wang Y, Liang X, Chen Y, Zhao X. 2016. Screening SIRT1 activators from medicinal plants as bioactive compounds against oxidative damage in mitochondrial function. Oxid. Med. Cell. Longev. 2016: 4206392.
  19. Huy TX, Reyes AW, Hop HT, Arayan LT, Min W, Lee HJ, et al. 2017. Intracellular trafficking modulation by ginsenoside Rg3 inhibits Brucella abortus uptake and intracellular survival within RAW 264.7 cells. J. Microbiol. Biotechnol. 27: 616-623. https://doi.org/10.4014/jmb.1609.09060
  20. Reyes AWB, Kim H, Huy TXN, Vu SH, Nguyen TT, Kang CK, et al. 2021. Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems. Microb. Pathog. 158: 105079.
  21. Yan L, Lu L, Hu F, Shetti D, Wei K. 2019. Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signaling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts. R. Soc. Open Sci. 6: 190360.
  22. Gomez G, Adams LG, Rice-Ficht A, Ficht TA. 2013. Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis. Front. Cell. Infect. Microbiol. 3: 17.
  23. Ko J, Splitter GA. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16: 65-78. https://doi.org/10.1128/CMR.16.1.65-78.2003
  24. Pei J, Kahl-McDonagh M, Ficht TA. 2014. Brucella dissociation is essential for macrophage egress and bacterial dissemination. Front. Cell. Infect. Microbiol. 4: 23.
  25. Chen X, Lu Y, Zhang Z, Wang J, Yang H, Liu G. 2015. Intercellular interplay between Sirt1 signaling and cell metabolism in immune cell biology. Immunology 145: 455-467. https://doi.org/10.1111/imm.12473
  26. Cheng CY, Gutierrez NM, Marzuki MB, Lu X, Foreman TW, Paleja B, et al. 2017. Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis. Sci. Immunol. 2: eaaj1789.
  27. Ahmed W, Zheng K, Liu ZF. 2016. Establishment of chronic infection: Brucella's stealth strategy. Front. Cell. Infect. Microbiol. 6: 30.
  28. Nijampatnam B, Zhang H, Cai X, Michalek SM, Wu H, Velu SE. 2018. Inhibition of Streptococcus mutans biofilms by the natural stilbene piceatannol through the inhibition of glucosyltransferases. ACS Omega 3: 8378-8385. https://doi.org/10.1021/acsomega.8b00367
  29. Bi S, Qu Y, Shao J, Zhang J, Li W, Zhang L, et al. 2022. Ginsenoside Rg3 ameliorates stress of broiler chicks induced by Escherichia coli lipopolysaccharide. Front. Vet. Sci. 9: 878018.
  30. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146. https://doi.org/10.1038/nri1001
  31. Guimaraes ES, Martins JM, Gomes MTR, Cerqueira DM, Oliveira SC. 2020. Lack of interleukin-6 affects IFN-γ and TNF-α production and early in vivo control of Brucella abortus infection. Pathogens 9: 1040.
  32. Shen P, Deng X, Chen Z, Ba X, Qin K, Huang Y, et al. 2021. SIRT1: A potential therapeutic target in autoimmune diseases. Front. Immunol. 12: 779177.
  33. Kim S, Lee DS, Watanabe K, Furuoka H, Suzuki H, Watarai M. 2005. Interferon-gamma promotes abortion due to Brucella infection in pregnant mice. BMC Microbiol. 5: 22.
  34. Zhan Y, Liu Z, Cheers C. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64: 2782-2786. https://doi.org/10.1128/iai.64.7.2782-2786.1996
  35. Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL. 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103: 511-518. https://doi.org/10.1046/j.1365-2567.2001.01258.x